Cygnet Labs Transaction from Brereton, Hanley & Co.

Cygnet Labs

Has been acquired by

The undersigned arranged
this transaction.

Cygnet is a leading provider of physiological information to the Health Care Industry. The company was started with angel venture capital.

The company quickly gained an impressive installed base in hospitals throughout the US due to its product superiority. However, a delay in migrating to the Windows operating system left the company strategically behind competition. The angel investor was not able to finance a rapid resolution to this problem and decided to seek a buyer.

The controlling angel shareholder engaged Brereton, Hanley to "shop" the company to other VC's and public firms. We managed the divestiture of Cygnet to Medical Technology Systems, Inc. (MSYS-OTC).

The owners received nominal present-value consideration for their stock, but received a handsome six-year royalty stream based on product revenue.

Client Reference Letter

Return to Related Industries

Return to Top of Page